Skip to main contentAll experts

ProfessorMichael Johnson, DPhil FRACP FRCP

Professor of Neurology and Genomic Medicine

Department of Brain Sciences - Faculty of Medicine

Orcid identifier0000-0002-5848-9342 (opens in a new tab)⁠
  • Professor of Neurology and Genomic Medicine
    Department of Brain Sciences - Faculty of Medicine
  • E419, Burlington Danes, Hammersmith Campus, United Kingdom

RESEARCH

Genetics and genomics of brain disease, including single-cell causal inference for drug target and predictive biomarker discovery and validation. Drug Development from target and biomarker discovery through pre-clinical and clinical development. Drug repurposing.

GRANTS

  • GRANT
    A quantitative microscopy platform to characterise GPNMB-mediated suppression of aggregate uptake and spreading
    Alzheimer's Research UK (ARUK)1 Oct 2024 - 30 Sep 2030
    Alzheimer's Research UK (ARUK): A quantitative microscopy platform to characterise GPNMB-mediated suppression of aggregate uptake and spreading (2024-2030)
  • STANDARD - RESPONSE
    Development of an antisense oligonucleotide (ASO) therapy targeting GPNMB for disease modification in Parkinson¿s disease.
    Parkinson's UK1 May 2024 - 30 Apr 2025
    Parkinson's UK: Development of an antisense oligonucleotide (ASO) therapy targeting GPNMB for disease modification in Parkinson¿s disease. (2024-2025)
  • GRANT
    Imperial CoA MRC
    Medical Research Council (MRC)1 Sep 2020 - 1 Dec 2023
    MRC: Imperial CoA MRC (2020-2021)